Evidence map›Paper›PMID 38879602›Full record

ArticleNature communications2024

Deep cell phenotyping and spatial analysis of multiplexed imaging with TRACERx-PHLEX.

Alastair Magness, Emma Colliver, Katey S S Enfield, Claudia Lee, Masako Shimato, Emer Daly, David A Moore, Monica Sivakumar, Karishma Valand, Dina Levi and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Spatial Multiomics Reveal Insights Into ADC Efficacy.European journal of immunology · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Alastair Magness *Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. alastair.magness@crick.ac.uk.
Emma Colliver *Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-1497-0740
Katey S S Enfield *Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-4551-6073
Claudia LeeCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-1715-2265
Masako ShimatoCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0001-9776-0935
Emer DalyCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
David A MooreCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-6296-1312
Monica SivakumarCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Karishma ValandOncogene Biology Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-9158-5782
Dina LeviFlow Cytometry, The Francis Crick Institute, London, UK.
Crispin T HileyCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Philip S HobsonFlow Cytometry, The Francis Crick Institute, London, UK.
Febe van MaldegemOncogene Biology Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-2544-544X
James L ReadingCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.ORCID http://orcid.org/0000-0001-5381-978X
Sergio A QuezadaCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.ORCID http://orcid.org/0000-0002-9763-1700
Julian DownwardOncogene Biology Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-2331-4729
Erik SahaiTumour Cell Biology Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-3932-5086
Charles SwantonCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.ORCID http://orcid.org/0000-0002-4299-3018
Mihaela AngelovaCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. mihaela.angelova@crick.ac.uk.ORCID http://orcid.org/0000-0002-0495-9695

Funding

Cancer Research UK (CRUK) C416/A21999EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101079113EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 838540Royal Society RF\ERE\210216Royal Society RF\ERE\231118Wellcome Trust CC2040Wellcome Trust CC2041
6 · The paper itself

Abstract

The growing scale and dimensionality of multiplexed imaging require reproducible and comprehensive yet user-friendly computational pipelines. TRACERx-PHLEX performs deep learning-based cell segmentation (deep-imcyto), automated cell-type annotation (TYPEx) and interpretable spatial analysis (Spatial-PHLEX) as three independent but interoperable modules. PHLEX generates single-cell identities, cell densities within tissue compartments, marker positivity calls and spatial metrics such as cellular barrier scores, along with summary graphs and spatial visualisations. PHLEX was developed using imaging mass cytometry (IMC) in the TRACERx study, validated using published Co-detection by indexing (CODEX), IMC and orthogonal data and benchmarked against state-of-the-art approaches. We evaluated its use on different tissue types, tissue fixation conditions, image sizes and antibody panels. As PHLEX is an automated and containerised Nextflow pipeline, manual assessment, programming skills or pathology expertise are not essential. PHLEX offers an end-to-end solution in a growing field of highly multiplexed data and provides clinically relevant insights.

Indexed as

Deep LearningAnimalsHumansImage CytometryImage Processing, Computer-AssistedMicePhenotypeSingle-Cell AnalysisSoftwareSpatial Analysis

Identifiers

PMID38879602
PMCPMC11180132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.